{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:25:29Z","timestamp":1761596729086},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,20]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Previously, we reported the identification of Pmel17 autoantibodies in some patients with vitiligo. Here, we have determined the B cell epitopes on Pmel17 which are recognized by these autoantibodies. Deletion derivatives of Pmel17 cDNA were constructed using either subcloning of specific cDNA fragments or polymerase chain reaction amplification. Full-length Pmel17 cDNA and its truncated derivatives were then translated in vitro to produce [35S]-labelled proteins. The radiolabelled ligands were used subsequently in radiobinding assays to investigate the reactivity of sera from vitiligo patients. Two epitope regions were identified: one located at the C-terminal end of Pmel17 between amino acids 634\u2013644 and one in a central region of the protein between amino acids 326\u2013341. Computer analysis of the potential B cell epitopes on Pmel17 revealed that the epitope domain encompassing amino acids 326\u2013341 was located in an area of the protein which was predicted to be highly antigenic. In contrast, the epitope identified at the C-terminal of Pmel17 (amino acids 634\u2013644) was located in a region of the protein predicted to have low antigenicity. The amino acid sequences of the identified Pmel17 epitopes were compared to the amino acid sequences of the related melanogenic enzymes tyrosinase, tyrosinase-related protein-1 and tyrosinase-related protein-2. However, no sequence homology was found between either of the Pmel17 epitopes and the aforementioned proteins. This finding is consistent with our previous study in which we were unable to show the presence of Pmel17 antibodies which were cross-reactive with either tyrosinase, tyrosinase-related protein-1 or tyrosinase-related protein-2. It also suggests that the IgG response to Pmel17 is distinct from the antibody response to the other melanocyte-specific antigens.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2001.01516.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:27:49Z","timestamp":1047378469000},"page":"509-515","source":"Crossref","is-referenced-by-count":20,"title":["Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo"],"prefix":"10.1093","volume":"124","author":[{"given":"E H","family":"Kemp","sequence":"first","affiliation":[{"name":"Division of Clinical Sciences, Northern General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E A","family":"Waterman","sequence":"additional","affiliation":[{"name":"Division of Clinical Sciences, Northern General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D J","family":"Gawkrodger","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P F","family":"Watson","sequence":"additional","affiliation":[{"name":"Division of Clinical Sciences, Northern General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A P","family":"Weetman","sequence":"additional","affiliation":[{"name":"Division of Clinical Sciences, Northern General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"2022011305533544300_b1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1523-1747.ep12522891","article-title":"Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation","volume":"81","author":"Naughton","year":"1983","journal-title":"J Invest Dermatol"},{"key":"2022011305533544300_b2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0190-9622(86)70260-0","article-title":"Correlation between vitiligo antibodies and extent of depigmentation in vitiligo","volume":"15","author":"Naughton","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"2022011305533544300_b3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"key":"2022011305533544300_b4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity (ADDC)","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"2022011305533544300_b5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1523-1747.ep12555773","article-title":"Identification of pigment cell antigens defined by vitiligo antibodies","volume":"98","author":"Cui","year":"1992","journal-title":"J Invest Dermatol"},{"key":"2022011305533544300_b6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"2022011305533544300_b7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"2022011305533544300_b8","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1073\/pnas.88.20.9228","article-title":"A melanocyte-specific gene, Pmel17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12","volume":"88","author":"Kwon","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011305533544300_b9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein Pmel17 in the sera of vitiligo patients: a sensitive and quantititative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"2022011305533544300_b10","doi-asserted-by":"crossref","first-page":"20126","DOI":"10.1016\/S0021-9258(17)32136-1","article-title":"Molecular characterisation of the melanocyte lineage-specific antigen gp100","volume":"269","author":"Adema","year":"1994","journal-title":"J Biol Chem"},{"key":"2022011305533544300_b11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/dna.1994.13.87","article-title":"Cloning and expression of the gene for the melanoma-associated ME20 antigen","volume":"13","author":"Maresh","year":"1994","journal-title":"DNA Cell Biol"},{"key":"2022011305533544300_b12","first-page":"489","article-title":"Melanocyte lineage-specific antigen gp100 is recognised by melanoma-derived tumor-infiltrating lymphocytes","volume":"178","author":"Bakker","year":"1994","journal-title":"J Exp Med"},{"key":"2022011305533544300_b13","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1073\/pnas.91.14.6458","article-title":"Identification of a human melanoma antigen recognised by tumor-infiltrating lymphocytes associated with in vivo tumor rejection","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011305533544300_b14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ijc.2910620118","article-title":"Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognised by an HLA-A2.1-restricted anti-melanoma CTL line","volume":"62","author":"Bakker","year":"1995","journal-title":"Int J Cancer"},{"key":"2022011305533544300_b15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1523-1747.1998.00354.x","article-title":"Antibody responses to melanoma\/melanocyte autoantigens in melanoma patients","volume":"111","author":"Huang","year":"1998","journal-title":"J Invest Dermatol"},{"key":"2022011305533544300_b16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4049\/jimmunol.156.2.818","article-title":"Glutamic acid decarboxylase autoantibodies in stiff\u2013man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition","volume":"156","author":"Daw","year":"1996","journal-title":"J Immunol"},{"key":"2022011305533544300_b17","first-page":"101","article-title":"Identification of epitopes on tyrosinase which are recognised by autoantibodies from patients with vitiligo","volume":"113","author":"Kemp","year":"1999","journal-title":"J Invest Dermatol"},{"key":"2022011305533544300_b18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-5793(93)80497-I","article-title":"Autoimmune Addison's disease. Analysis of autoantibody binding sites on human steroid 21-hydroxylase","volume":"332","author":"Wedlock","year":"1993","journal-title":"FEBS Lett"},{"key":"2022011305533544300_b19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00008390-199712000-00004","article-title":"Cloning expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100","volume":"7","author":"Schreurs","year":"1997","journal-title":"Melanoma Res"},{"key":"2022011305533544300_b20","volume-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"1989","edition":"2nd edn"},{"key":"2022011305533544300_b21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase autoantibodies in vitiligo patients using 35S-labelled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"key":"2022011305533544300_b22","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1021\/bi00367a013","article-title":"New hydrophilicity scale derived from high-performence liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites","volume":"25","author":"Parker","year":"1986","journal-title":"Biochemistry"},{"key":"2022011305533544300_b23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/0006-291X(89)90770-5","article-title":"Functional analysis of the cDNA encoding human tyrosinase precursor","volume":"162","author":"Takeda","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2022011305533544300_b24","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1093\/nar\/18.9.2807","article-title":"Nucleotide sequence of the cDNA encoding human tyrosinase-related protein","volume":"18","author":"Cohen","year":"1990","journal-title":"Nucl Acids Res"},{"key":"2022011305533544300_b25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0167-4781(94)90292-5","article-title":"Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase\/tyrosinase-related protein-2","volume":"1217","author":"Yokoyama","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"2022011305533544300_b26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00464702","article-title":"Methods of epitope mapping","volume":"16","author":"Petterson","year":"1992","journal-title":"Mol Biol Reports"},{"key":"2022011305533544300_b27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/thy.1999.9.467","article-title":"Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay","volume":"9","author":"Morgenthaler","year":"1999","journal-title":"Thyroid"},{"key":"2022011305533544300_b28","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.4049\/jimmunol.157.11.5208","article-title":"Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase","volume":"157","author":"Syren","year":"1996","journal-title":"J Immunol"},{"key":"2022011305533544300_b29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1365-2249.1998.00475.x","article-title":"A study of the eptitopes on steroid 21-hydroxylase recognised by autoantibodies in patients with or without Addison's disease","volume":"111","author":"Volpato","year":"1998","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01516.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01516.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/124\/3\/509\/42162641\/j.1365-2249.2001.01516.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/124\/3\/509\/42162641\/j.1365-2249.2001.01516.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T15:18:53Z","timestamp":1682090333000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/124\/3\/509\/6461403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,12,20]]},"published-print":{"date-parts":[[2001,12,20]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2001.01516.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,6]]},"published":{"date-parts":[[2001,6]]}}}